Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06968975 · ClinicalTrials.gov registry record
Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)
A clinical trial of Polyneuropathy, Inflammatory Demyelinating, Chronic, sponsored by Sanofi.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT06968975 is a study of Polyneuropathy, Inflammatory Demyelinating, Chronic that is actively recruiting participants, run by Sanofi. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06968975, a study of Polyneuropathy, Inflammatory Demyelinating, Chronic, is actively recruiting participants, sponsored by Sanofi.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This study is an observational, ambispective, descriptive, non-interventional study of people with a chronic inflammatory demyelinating polyneuropathy/polyradiculoneuropathy (CIDP) diagnosis in the United States with residual impairment, disability, or neurological deficits after at least three months of treatment with standard of care therapy. The study is expected to last two years. Enrollment is expected to continue for one year. Depending on when the participant is enrolled, a participant can be followed for between one and two years, through the end of study, approximately two years after the study starts.
Conditions Studied
Study Locations (1)
Pennsylvania
- Investigational Site - Swiftwater
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-04-11 |
| Est. Completion | 2027-05-17 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06968975
The ClinicalTrials.gov registry entry for NCT06968975 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Sanofi, which has 713 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Polyneuropathy, Inflammatory Demyelinating, Chronic appearing as the primary indexed condition, and to 0 interventions.
NCT06968975 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT06968975 about?
NCT06968975 is a clinical study titled "Real-world Study of Treatment Outcomes in Chronic Inflammatory Demyelinating Polyneuropathy/Polyradiculoneuropathy (CIDP)". This study is an observational, ambispective, descriptive, non-interventional study of people with a chronic inflammatory demyelinating polyneuropathy/polyradiculoneuropathy (CIDP) diagnosis in the United States with residual impairment, disability, or neurological deficits after at least three mont...
What is the current status of trial NCT06968975?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-04-11. Estimated completion is 2027-05-17.
What conditions does trial NCT06968975 study?
This clinical trial studies the following conditions: Polyneuropathy, Inflammatory Demyelinating, Chronic.
Who is sponsoring clinical trial NCT06968975?
This trial is sponsored by Sanofi, which has 713 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06968975 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Polyneuropathy, Inflammatory Demyelinating, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.